O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y

Biochemical and Biophysical Research Communications

Volumn 382, Issue 3, 2009, Pages 593-597

  Lim, Kihong ^a   Chang, Hyo Ihl ^a  

^a Korea University   (South Korea)

Author keywords

NF Y; O GlcNAc; Sp1; Transcription with NF Y

Indexed keywords

N ACETYLGLUCOSAMINE; NF Y TRANSCRIPTION FACTOR; SERINE; THREONINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; EMBRYO; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MODULATION; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM;

ACETYLGLUCOSAMINE; ACYLATION; CCAAT-BINDING FACTOR; CELL LINE; HUMANS; IMMUNOPRECIPITATION; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 64049092248     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.075     Document Type: Article

References (25)

1. Wierstra I. Sp1: Emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 372 (2008) 1-13
2. Kadonaga J.T., Courey A.J., Ladika J., and Tjian R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 242 (1988) 1566-1570
3. Chu S., and Ferro T.J. Sp1: regulation of gene expression by phosphorylation. Gene 348 (2005) 1-11
4. Jackson S.P., and Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 55 (1988) 125-133
5. Roos M.D., Su K., Baker J.R., and Kudlow J.E. O-glycosylation of a Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 17 (1997) 6472-6480
6. Yang X., Su K., Roos M.D., Chang Q., and Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. USA 98 (2001) 6611-6616
7. Lim K., and Chang H.I. O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1. FEBS Lett. 580 (2006) 4645-4652
8. Lim K., and Chang H.I. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. FEBS Lett. 583 (2009) 512-520
9. Lim K., and Chang H.I. O-GlcNAc inhibits interaction between Sp1 and Elf-1 transcription factors. Biochem. Biophys. Res. Commun. 380 (2009) 569-574
10. R. Jochmann, M. Thurau, S. Jung, C. Hofmann, E. Naschberger, E. Kremmer, T. Harrer, M. Miller, N. Schaft, M. Sturzl, O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type-1 promoter, J. Virol., in press, doi:10.1128/JVI.01384-08.
11. Mantovani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239 (1999) 15-27
12. Mantovani R., Pessara1 U., Tronche F., Li X.-Y., Knapp A.-M., Pasquali J.-L., Benoist C., and Mathis D. Monoclonal antibodies to NF-Y define its function in MHC class 11 and albumin gene transcription. EMBO J. 11 (1992) 3315-3322
13. Yamada K., Tanaka T., Miyamoto K., and Noguchi T. Sp family members and nuclear factor-Y cooperatively stimulate transcription from the rat pyruvate kinase M gene distal promoter region via their direct interactions. J. Biol. Chem. 275 (2000) 18129-18137
14. Iwano S., Saito T., Takahashi Y., Fujita K.-I., and Kanataki T. Cooperative regulation of CYP3A5 gene transcription by NF-Y and Sp family members. Biochem. Biophys. Res. Commun. 286 (2001) 55-60
15. Jun D.Y., Park H.S., Lee J.Y., Baek J.Y., Park H.K., Fukui K., and Kim Y.H. Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y. Gene 414 (2008) 106-114
16. Yubin G.E., Konrad M.A., Matherly L.H., and Taub J.W. Transcription regulation of human cystathionine β-synthase-1b basal promoter: synergistic transcription by transcription factors NF-Y and Sp1/Sp3. Biochem. J. 357 (2001) 97-105
17. Zhong Z.D., Hammani K., Bae W.S., and DeClerck Y.A. NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human inhibitor of metalloproteinases-2. J. Biol. Chem. 275 (2000) 18602-18610
18. Jean D., Guillaume N., Frade R., and promoter C.o.h.c.L. Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity. Biochem. J. 361 (2002) 173-184
19. Roder K., Wolf S.S., Larkin K.J., and Schweizer M. Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene 234 (1999) 61-69
20. Toleman C., Paterson A.J., Shin R., and Kudlow J.E. Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog. Biochem. Biophys. Res. Commun. 340 (2006) 526-534
21. Yang W.H., Kim J.E., Nam H.W., Ju J.W., Kim H.S., Kim Y.S., and Cho J.W. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8 (2006) 1074-1083
22. Majumdar G., Harrington A., Hungerford J., Martinez-Hernandez A., Gerling I.C., Raghow R., and Solomon S. Insulin dynamically regulates calmodulin gene expression by sequential O-glycosylation and phosphorylation of Sp1 and its subcellular compartmentalization in liver cells. J. Biol. Chem. 281 (2006) 3642-3650
23. Copeland R.J., Bullen J.W., and Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol. Endocrinol. Metab. 295 (2008) E17-28
24. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
25. Bowe B.D., Sadlonova A., Toleman C.A., Novak Z., Hu Y., Huang P., Mukherjee S., Whitsett T., Frost A.R., Paterson A.J., and Kudlow J.E. O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors. Mol. Cell. Biol. 26 (2006) 8539-8550